Bogdana Schmidt
Rating: 4.9 of 5
( out of 341 reviews )

Bogdana Schmidt, MD, MPH

Languages spoken: English, Russian, Spanish, Ukrainian

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Urology
1950 Circle of Hope
Salt Lake City , UT 84112
801-587-4381
Get Directions

Veterans Administration Medical Center

500 S Foothill Blvd
Salt Lake City , UT 84148
Get Directions

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended the University of California, San Francisco School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:
    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.
    • Novel imaging technologies
    • Organ preservation
    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:
    • Improving patient risk stratification and optimization of surgical outcomes
    • Quality improvement in urologic oncology
    • Addressing health disparities in urologic oncology
    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Specialties

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 341 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    October 30, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Even though her surgical involvement in my case has ended, Dr Schmidt insists on remaining involved in my medical oncologic care. This is unheard of in today's medical systems! She learned from the best--Dr Chris Dechet--and has improved on his already high standards!

    October 22, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Schmidt was, as usual, driven, focussed, and full of information to share, and at the same time an excellent proceduralist. She is wonderful.

    October 22, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Schmidt is one of my favorite doctors. She is caring and very patient, explaining everything about my care. I am so glad she was my surgeon!

    October 15, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Bogdana Schmidt in my opinion is a great doctor. I wish you were more doctors like her. Thank you.

    October 12, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    If you get the opportunity to have Dr. Bogdana Schmidt rest assured that you will get the best care possible....

    October 09, 2025
    HUNTSMAN CANCER CENTER
    Rating: 3 out of 5

    She was straightforward

    October 09, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    I am at ease with whatever procedure/surgery is next. Professional, knowledgeable, confident, positive.

    October 06, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Very good Dr. Exceptional bedside manner (Rare nowadays) Trusting demeanor, this includes acting with integrity. You can tell she's a very nice person as well.

    October 01, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Schmidt is the best physician I've encountered. She has been a blessing to me. She's professional, skilled and as compassionate a doctor as I've met. Highly recommend her for urological cancer care.

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended the University of California, San Francisco School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:
    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.
    • Novel imaging technologies
    • Organ preservation
    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:
    • Improving patient risk stratification and optimization of surgical outcomes
    • Quality improvement in urologic oncology
    • Addressing health disparities in urologic oncology
    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Board Certification and Academic Information

    Academic Departments Surgery -Assistant Professor (Clinical)
    Academic Divisions Urology

    Education history

    Fellowship Urologic Oncology - Stanford University Fellow
    Residency Urologic Surgery - University of California, San Francisco Resident
    Internship General Surgery - University of California, San Francisco Intern
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Graduate Training Community Health Science - University of California, Los Angeles M.P.H.
    Undergraduate Physiological Science - University of California, Los Angeles B.S.

    Selected Publications

    Journal Article

    1. Fadlullah MZH, Nix D, Herberts C, Maurice-Dror C, Wyatt AW, Schmidt B, Fairbourn B, Tan AC, Wang L, Kohli M (2025). Multi-gene risk-score for prediction of clinical outcomes in treatment-naïve metastatic castrate resistant prostate cancer. JNCI Cancer Spectr, 9(2). (Read full publication)
    2. Schmidt B, Soerensen SJC, Bhambhvani HP, Fan RE, Bhattacharya I, Choi MH, Kunder CA, Kao CS, Higgins J, Rusu M, Sonn GA (2024). External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens. BJU Int, 135(1), 133-139. (Read full publication)
    3. Soerensen SJC, Schmidt B, Thomas IC, Montez-Rath ME, Thong AE, Prado K, Shah JB, Skinner EC, Leppert JT (2024). An Automated Electronic Health Record Score to Estimate Length of Stay and Readmission in Patients Undergoing Radical Cystectomy for Bladder Cancer. J Urol, 213(1), 52-59. (Read full publication)
    4. Dindinger-Hill K, Hu S, Hickman A, Choudry M, Vehawn J, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Kohli M, ONeil B, Schmidt B, Dechet C, Hashibe M, Sanchez A (2024). Association of Baseline Pre-Diagnosis and Post-Diagnosis Obesity and Weight Change with Cardiovascular Risk and Survival Among Nonmetastatic Prostate Cancer Survivors. Clin Genitourin Cancer, 22(3), 102057. (Read full publication)
    5. Sung D, Schmidt B, Tward JD (2024). The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer. Clin Genitourin Cancer. (Read full publication)
    6. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459. (Read full publication)
    7. Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT (2022). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci, 35, 29-36. (Read full publication)
    8. Vilson FL, Schmidt B, White L, Sorensen SJC, Ganesan C, Pao AC, Enemchukwu E, Chertow GM, Leppert JT (2021). Removing Race from eGFR calculations: Implications for Urologic Care. Urology. (Read full publication)
    9. Schmidt B, Leppert JT (2021). Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later? JAMA Netw Open, 4(3), e212548. (Read full publication)
    10. Schmidt B, Bhambhvani HP, Greenberg DR, Prado K, Shafer S, Thong A, Gill H, Skinner E, Shah JB (2020). Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? Urol Oncol. (Read full publication)
    11. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR (2018). Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis, 22(1), 117-124. (Read full publication)
    12. Schmidt B, Meng MV, Hampson LA (2018). Operating Room Supply Cost Awareness: A Cross-Sectional Analysis. Urol Pract, 6(2), 73-78. (Read full publication)
    13. Truesdale MD, Elmer-Dewitt M, Sandri M, Schmidt B, Metzler I, Gadzinski A, Stoller ML, Chi T (2016). Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy. J Endourol, 30(4), 476-82. (Read full publication)
    14. Schmidt B, Copp HL (2015). Work-up of Pediatric Urinary Tract Infection. Urol Clin North Am, 42(4), 519-26. (Read full publication)
    15. Kovshilovskaya B, Chi T, Miller J, Stoller ML (2016). Systemic implications of urinary stone disease. Transl Androl Urol, 1(2), 89-96. (Read full publication)
    16. Weiss DA, Kovshilovskaya B, Breyer BN (2011). Gender trends of urology manuscript authors in the United States: a 35-year progression. J Urol, 187(1), 253-8. (Read full publication)
    17. Call GB, Olson JM, Chen J, Villarasa N, Ngo KT, Yabroff AM, Cokus S, Pellegrini M, Bibikova E, Bui C, Cespedes A, Chan C, Chan S, Cheema AK, Chhabra A, Chitsazzadeh V, Do MT, Fang QA, Folick A, Goodstein GL, Huang CR, Hung T, Kim E, Kim W, Kim Y, Kohan E, Kuoy E, Kwak R, Lee E, Lee J, Lin H, Liu HC, Moroz T, Prasad T, Prashad SL, Patananan AN, Rangel A, Rosselli D, Sidhu S, Sitz D, Taber CE, Tan J, Topp K, Tran P, Tran QM, Unkovic M, Wells M, Wickland J, Yackle K, Yavari A, Zaretsky JM, Allen CM, Alli L, An J, Anwar A, Arevalo S, Ayoub D, Badal SS, Baghdanian A, Baghdanian AH, Baumann SA, Becerra VN, Chan HJ, Chang AE, Cheng XA, Chin M, Chong F, Crisostomo C, Datta S, Delosreyes A, Diep F, Ekanayake P, Engeln M, Evers E, Farshidi F, Fischer K, Formanes AJ, Gong J, Gupta R, Haas BE, Hahm V, Hsieh M, Hui JZ, Iao ML, Jin SD, Kim AY, Kim LS, King M, Knudsen-Robbins C, Kohanchi D, Kovshilovskaya B, Ku A, Kung RW, Landig ME, Latterman SS, Lauw SS, Lee DS, Lee JS, Lei KC, Leung LL, Lerner R, Lin JY, Lin K, Lim BC, Lui CP, Liu TQ, Luong V, Makshanoff J, Mei AC, Meza M, Mikhaeil YA, Moarefi M, Nguyen LH, Pai SS, Pandya M, Patel AR, Picard PD, Safaee MM, Salame C, Sanchez C, Sanchez N, Seifert CC, Shah A, Shilgevorkyan OH, Singh I, Soma V, Song JJ, Srivastava N, StaAna JL, Sun C, Tan D, Teruya AS, Tikia R, Tran T, Travis EG, Trinh JD, Vo D, Walsh T, Wong RS, Wu K, Wu YW, Yang NX, Yeranosian M, Yu JS, Zhou JJ, Zhu RX, Abrams A, Abramson A, Amado L, Anderson J, Bashour K, Beyer E, Bookatz A, Brewer S, Buu N, Calvillo S, Cao J, Chan A, Chan J, Chang A, Chang D, Chang Y, Chen Y, Choi J, Chou J, Dang P, Datta S, Davarifar A, Deravanesian A, Desai P, Fabrikant J, Farnad S, Fu K, Garcia E, Garrone N, Gasparyan S, Gayda P, Go S, Goffstein C, Gonzalez C, Guirguis M, Hassid R, Hermogeno B, Hong J, Hong A, Hovestreydt L, Hu C, Huff D, Jamshidian F, Jen J, Kahen K, Kao L, Kelley M, Kho T, Kim Y, Kim S, Kirkpatrick B, Langenbacher A, Laxamana S, Lee J, Lee C, Lee SY, Lee TS, Lee T, Lewis G, Lezcano S, Lin P, Luu T, Luu J, Marrs W, Marsh E, Marshall J, Min S, Minasian T, Minye H, Misra A, Morimoto M, Moshfegh Y, Murray J, Nguyen K, Nguyen C, Nodado E 2nd, ODonahue A, Onugha N, Orjiakor N, Padhiar B, Paul E, Pavel-Dinu M, Pavlenko A, Paz E, Phaklides S, Pham L, Poulose P, Powell R, Pusic A, Ramola D, Regalia K, Ribbens M, Rifai B, Saakyan M, Saarikoski P, Segura M, Shadpour F, Shemmassian A, Singh R, Singh V, Skinner E, Solomin D, Soneji K, Spivey K, Stageberg E, Stavchanskiy M, Tekchandani L, Thai L, Thiyanaratnam J, Tong M, Toor A, Tovar S, Trangsrud K, Tsang WY, Uemura M, Vollmer E, Weiss E, Wood D, Wu J, Wu S, Wu W, Xu Q, Yamauchi Y, Yarosh W, Yee L, Yen G, Banerjee U (2007). Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics, 177(2), 689-97. (Read full publication)

    Review

    1. Zhu GG, Siegel CL, Rogers DM, Sagel J, Morrell G, Olpin JD, Schmidt B, Hoegger MJ (2025). Urinary bladder diverticula: imaging features and complications. [Review]. Abdom Radiol (NY), 50(8), 3584-3598. (Read full publication)
    2. Filon M, Schmidt B (2025). New Treatment Options for Non-Muscle-Invasive Bladder Cancer. [Review]. Am Soc Clin Oncol Educ Book, 45(2), e471942. (Read full publication)

    Commentary

    1. Schmidt B, Agarwal N (2021). Black Men Receiving Radiotherapy for Localized Prostate Cancer Have Improved Outcomes-Clinical Trial Access or Racial Advantage? JAMA Netw Open, 4(12), e2140692. (Read full publication)

    Case Report

    1. Vilson FL, Lin SY, Schmidt B (2020). Resolution of bilateral testicular masses after viral infection. Urol Case Rep, 33, 101388. (Read full publication)

    Editorial

    1. Filon M, Schmidt B (2024). Editorial Comment. J Urol, 212(4), 599. (Read full publication)
    2. Bergman J, Schmidt B, Leppert JT (2020). Following Up on an Improperly Drawn Screening Test: The PSA Dilemma. Am J Med, 134(3), e145-e146. (Read full publication)

  • News & Podcasts

    Huntsman Cancer Institute News